RSS Search

News  Feeds  Tags  Search Shortcuts

FeedsFarm.com > AHA: Actos (pioglitazone) May Slow Progression of Atherosclerosis

AHA: Actos (pioglitazone) May Slow Progression of Atherosclerosis

14th Nov 2006, 18:17 GMT

CHICAGO -- In a head-to-head trial with the sulfonylurea Amaryl (glimepiride), Actos (pioglitazone), a thiazolidinedione, appeared to slow the progression of a marker for atherosclerosis in patients with type 2 diabetes, researchers reported here.

View full story at www.medpagetoday.com

AHA: Actos (pioglitazone) May Slow Progression of Atherosclerosis related news:

Latest news from MedPage Today.com Latest Headlines: